In Silico Preliminary Association of Ammonia Metabolism Genes GLS, CPS1, and GLUL with Risk of Alzheimer’s Disease, Major Depressive Disorder, and Type 2 Diabetes

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Journal of Molecular Neuroscience

• Publication date

  2018-02-13

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s12031-018-1035-0PMID 29441491
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Brain changes in overweight/obese and normal-weight adults with type 2 diabetes mellitus

  2017cited by this paper
• Effect of memantine combination therapy on symptoms in patients with moderate‐to‐severe depressive disorder: randomized, double‐blind, placebo‐controlled study

  2017cited by this paper
• Assessing the presence of shared genetic architecture between Alzheimer's disease and major depressive disorder using genome-wide association data

  2017cited by this paper
• An excessive increase in glutamate contributes to glucose-toxicity in β-cells via activation of pancreatic NMDA receptors in rodent diabetes

  2017cited by this paper
• Foxp3 Reprograms T Cell Metabolism to Function in Low-Glucose, High-Lactate Environments.

  2017cited by this paper
• Graded perturbations of metabolism in multiple regions of human brain in Alzheimer's disease: Snapshot of a pervasive metabolic disorder

  2016cited by this paper
• Central Role of Glutamate Metabolism in the Maintenance of Nitrogen Homeostasis in Normal and Hyperammonemic Brain

  2016cited by this paper
• The Role of FOXP3 in Human Cancers.

  2016cited by this paper
• Activation-dependent mitochondrial translocation of Foxp3 in human hepatocytes.

  2016cited by this paper
• β‐Cell glutamate signaling: Its role in incretin‐induced insulin secretion

  2016cited by this paper
• Shared genetic etiology underlying Alzheimer's disease and type 2 diabetes.

  2015cited by this paper
• Link between type 2 diabetes and Alzheimer’s disease: from epidemiology to mechanism and treatment

  2015cited by this paper
• RegNetwork: an integrated database of transcriptional and post-transcriptional regulatory networks in human and mouse

  2015cited by this paper
• Characterization of pancreatic NMDA receptors as possible drug targets for diabetes treatment

  2015cited by this paper
• Tissue-based map of the human proteome

  2015cited by this paper
• The case for rejecting the amyloid cascade hypothesis

  2015cited by this paper
• Q&A: insulin secretion and type 2 diabetes: why do β-cells fail?

  2015cited by this paper
• Shared Genetic Etiology between Type 2 Diabetes and Alzheimer’s Disease Identified by Bioinformatics Analysis

  2015cited by this paper
• The Concordance and Heritability of Type 2 Diabetes in 34,166 Twin Pairs From International Twin Registers: The Discordant Twin (DISCOTWIN) Consortium

  2015cited by this paper
• Association of type 2 diabetes GWAS loci and the risk of Parkinson's and Alzheimer's diseases.

  2015cited by this paper
• Genetic Variant at the GLUL Locus Predicts All-Cause Mortality in Patients With Type 2 Diabetes

  2015cited by this paper
• Alleles that increase risk for type 2 diabetes mellitus are not associated with increased risk for Alzheimer's disease.

  2014cited by this paper
• Possible synergistic effect of direct angiotensin II type 2 receptor stimulation by compound 21 with memantine on prevention of cognitive decline in type 2 diabetic mice.

  2014cited by this paper
• Glutamate as a neurotransmitter in the healthy brain

  2014cited by this paper
• Establishing genomic/transcriptomic links between Alzheimer's disease and type 2 diabetes mellitus by meta-analysis approach.

  2014cited by this paper
• Glutamate and GABA-Metabolizing Enzymes in Post-mortem Cerebellum in Alzheimer’s Disease: Phosphate-Activated Glutaminase and Glutamic Acid Decarboxylase

  2014cited by this paper
• The Role of FOXP3 in Regulating Immune Responses

  2014cited by this paper
• Glutamate Acts as a Key Signal Linking Glucose Metabolism to Incretin/cAMP Action to Amplify Insulin Secretion

  2014cited by this paper
• Diabetes mellitus and risk of dementia: A meta‐analysis of prospective observational studies

  2013cited by this paper
• Gene expression deficits in pontine locus coeruleus astrocytes in men with major depressive disorder.

  2013cited by this paper
• Amyloid β, Glutamate, Excitotoxicity in Alzheimer's Disease: Are We on the Right Track?

  2013cited by this paper
• Astrocytes and glutamate homoeostasis in Alzheimer's disease: a decrease in glutamine synthetase, but not in glutamate transporter-1, in the prefrontal cortex

  2013cited by this paper
• Alzheimer’s disease: amino acid levels and brain metabolic status

  2013cited by this paper
• Glutamine deficiency in the prefrontal cortex increases depressive-like behaviours in male mice.

  2013cited by this paper
• Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders.

  2012cited by this paper
• HTRIdb: an open-access database for experimentally verified human transcriptional regulation interactions

  2012cited by this paper
• Regional cortical thinning in patients with major depressive disorder: a surface-based morphometry study.

  2012cited by this paper
• Association of depression with increased risk of dementia in patients with type 2 diabetes: the Diabetes and Aging Study.

  2012cited by this paper
• Hyperammonemia in review: pathophysiology, diagnosis, and treatment

  2012cited by this paper
• Glial and glutamatergic markers in depression, alcoholism, and their comorbidity.

  2010cited by this paper
• Glutamate receptors, neurotoxicity and neurodegeneration

  2010cited by this paper
• Incretin-Based Therapies for the Treatment of Type 2 Diabetes: Evaluation of the Risks and Benefits

  2010cited by this paper
• Altered expression of glutamate signaling, growth factor and glia genes in the locus coeruleus of patients with major depression

  2010cited by this paper
• DNA Specificity Determinants Associate with Distinct Transcription Factor Functions

  2009cited by this paper
• Highly variable clinical phenotype of carbamylphosphate synthetase 1 deficiency in one family: an effect of allelic variation in gene expression?

  2009cited by this paper
• Human Splicing Finder: an online bioinformatics tool to predict splicing signals

  2009cited by this paper
• History of depression, depressive symptoms, and medial temporal lobe atrophy and the risk of Alzheimer disease

  2008cited by this paper
• Analyses of the National Institute on Aging Late-Onset Alzheimer's Disease Family Study: implication of additional loci.

  2008cited by this paper
• PLINK: a tool set for whole-genome association and population-based linkage analyses.

  2007cited by this paper
• Evolutionarily conserved multisubunit RBL2/p130 and E2F4 protein complex represses human cell cycle-dependent genes in quiescence.

  2007cited by this paper
• Different regional patterns of cortical thinning in Alzheimer's disease and frontotemporal dementia.

  2006cited by this paper
• The prevalence of co‐morbid depression in adults with Type 2 diabetes: a systematic review and meta‐analysis

  2006cited by this paper
• Haploview: analysis and visualization of LD and haplotype maps

  2005cited by this paper
• Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression

  2005cited by this paper
• Aggregation of vascular risk factors and risk of incident Alzheimer disease

  2005cited by this paper
• Opposing roles of E2Fs in cell proliferation and death

  2004cited by this paper
• Increased risk of type 2 diabetes in Alzheimer disease.

  2004cited by this paper
• The Biology of the Ets1 Proto-Oncogene

  2003cited by this paper
• Ammonia and Alzheimer's disease.

  2002cited by this paper
• Glutamine synthetase in brain: effect of ammonia.

  2002cited by this paper
• The prevalence of comorbid depression in adults with diabetes: a meta-analysis.

  2001cited by this paper
• Neuronal expression of glutamine synthetase in Alzheimer's disease indicates a profound impairment of metabolic interactions with astrocytes.

  2000cited by this paper
• Genetic epidemiology of major depression: review and meta-analysis.

  2000cited by this paper
• Diabetes mellitus and the risk of dementia

  1999cited by this paper
• Adverse psychological impact, glutamatergic dysfunction, and risk factors for Alzheimer's disease.

  1998cited by this paper
• Prenatal diagnosis of carbamoyl phosphate synthetase I deficiency by identification of a missense mutation in CPS1

  1998cited by this paper
• Heritability for Alzheimer's disease: the study of dementia in Swedish twins.

  1997cited by this paper
• Expression and role of ionotropic glutamate receptors in pancreatic islet cells

  1995cited by this paper
• Ammonia metabolism and the urea cycle: function and clinical implications.

  1994cited by this paper
• Plasma concentrations of glutamate and its metabolites in patients with Alzheimer's disease.

  1993cited by this paper
• Plasma concentrations of glutamate and its metabolites in patients with Alzheimer's disease

  1993cited by this paper
• Is ammonia a pathogenetic factor in Alzheimer's disease?

  1993cited by this paper
• Alzheimer's disease: the amyloid cascade hypothesis.

  1992cited by this paper
• Ammonia is endogenously generated in the brain in the presence of presumed and verified dementia of Alzheimer type.

  1990cited by this paper
• Loss of glutaminase-positive cortical neurons in Alzheimer's disease

  1989cited by this paper
• Cortical Glutaminase, β-Glucuronidase and Glucose Utilization in Alzheimer's Disease

  1989cited by this paper
• Synaptic transmission in ammonia intoxication.

  1987cited by this paper
• The maximal activity of phosphate-dependent glutaminase and glutamine metabolism in the colon and the small intestine of streptozotocin-diabetic rats

  1987cited by this paper
• Carbamyl phosphate synthetase I deficiency with no detectable mRNA activity

  1986cited by this paper
• Hyperammonemia in Alzheimer's disease.

  1985cited by this paper

• CPS1: a multipurpose mitochondrial enzyme, bile protein, acute liver injury biomarker, and cytokine

  2026cites this paper
• Controllability of morphometric network colocalize with underlying neurobiology in major depression

  2026cites this paper
• Ammonia – an old metabolite brings new insights into Alzheimer’s disease

  2025cites this paper
• Ammonia Dynamics in the Human Body: Insights in Biomedical Sensing Technologies

  2025cites this paper
• Complementary Strategies to Identify Differentially Expressed Genes in the Choroid Plexus of Patients with Progressive Multiple Sclerosis

  2025cites this paper
• Novel Pathological Mechanisms Revealed by Spatial Transcriptomic Analysis of Hippocampus in Aged Control, Primary Age-Related Tauopathy, and Alzheimer’s Disease

  2025cites this paper
• Cuproptosis and copper as potential mechanisms and intervention targets in Alzheimer's disease.

  2025cites this paper
• Hub genes, key miRNAs and interaction analyses in type 2 diabetes mellitus: an integrative in silico approach.

  2024cites this paper
• The Effect of glna Loss on the Physiological and Pathological Phenotype of Parkinson's Disease C. elegans

  2024cites this paper
• Identification and interaction analysis of molecular markers in myocardial infarction by bioinformatics and next-generation sequencing data analysis

  2024cites this paper
• Construction and validation of a bioinformatics‑based screen for cuproptosis‑related genes and risk model for Alzheimer's disease.

  2024cites this paper
• Metabolic phenotyping reveals an emerging role of ammonia abnormality in Alzheimer’s disease

  2024cites this paper
• Longitudinal Neuropathological Consequences of Extracranial Radiation Therapy in Mice

  2024cites this paper
• Human neural stem cells restore spatial memory in a transgenic Alzheimer’s disease mouse model by an immunomodulating mechanism

  2023cites this paper
• Bioinformatics Analysis of Next Generation Sequencing Data Identifies Molecular Biomarkers Associated With Type 2 Diabetes Mellitus

  2023cites this paper
• Shared peripheral blood biomarkers for Alzheimer’s disease, major depressive disorder, and type 2 diabetes and cognitive risk factor analysis

  2023cites this paper
• Unraveling the therapeutic potential of carbamoyl phosphate synthetase 1 (CPS1) in human diseases.

  2022cites this paper
• Screening key genes and signaling pathways in COVID-19 infection and its associated complications by integrated bioinformatics analysis

  2021cites this paper
• Identification of candidate biomarkers and therapeutic agents for heart failure by bioinformatics analysis

  2021cites this paper
• Analysis of key genes and pathways associated with the pathogenesis of Type 2 diabetes mellitus

  2021cites this paper
• Identification of candidate biomarkers and pathways associated with type 1 diabetes mellitus using bioinformatics analysis

  2021cites this paper
• Glutaminase inhibitory activities of pentacyclic triterpenes isolated from Thymus vulgaris L.

  2021cites this paper
• Identification and Interaction Analysis of Molecular Markers in Myocardial Infarction by Integrated Bioinformatics Analysis

  2021cites this paper
• A Comprehensive Analysis of Unique and Recurrent Copy Number Variations in Alzheimer's Disease and its Related Disorders.

  2020cites this paper
• CPS1: Looking at an ancient enzyme in a modern light.

  2020cites this paper
• A constitutive knockout of murine carbamoyl phosphate synthetase 1 results in death with marked hyperglutaminemia and hyperammonemia

  2019cites this paper
• Integrative Analyses of Genes Associated with Subcutaneous Insulin Resistance

  2019cites this paper